Quick Links

The antianginal agent ranolazine is a potent antiarrhythmic agent that reduces ventricular arrhythmias: through a mechanism favo

Authors: Robert A Kloner|||Joan S Dow|||Anil Bhandari

Journal: Cardiovascular therapeutics

Publication Type: Journal Article

Date: 2011

DOI: 10.1111/j.1755-5922.2010.00203.x

ID: 20626400

Affiliations:

Affiliations

    The Heart Institute, Good Samaritan Hospital, Los Angeles, CA 90017, USA. rkloner@goodsam.org||||||

Abstract

The antianginal agent ranolazine (R) has shown some promise as an antiarrhythmic agent but its mechanism of action is not known. Previously, we have shown that R suppresses ventricular arrhythmias at a concentration >10 μM that may affect multiple ion currents including IKr.


Chemical List

    Acetanilides|||Anti-Arrhythmia Agents|||Piperazines|||Sodium Channel Blockers|||Ranolazine